OriGene Antibodies in recent publications
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas Blood, Mar 2013; 121: 2563 - 2566.
Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium Biol Reprod, Mar 2013; 88: 79.
RNA elements directing in vivo assembly of the 7SK/MePCE/Larp7 transcriptional regulatory snRNP Nucleic Acids Res., Mar 2013; 10.1093/nar/gkt159.
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements Haematologica, Mar 2013; 98: 404 - 408.
View All Citations >>
Home All anti-JAK2 antibodies
Anti-JAK2 Phospho Antibody
Also for JAK2 (NM_004972)
Homo sapiens Janus kinase 2 (JAK2)
The antiserum was produced against synthesized phosphopeptide derived from human JAK2 around the phosphorylation site of tyrosine 750 (G-D-YP-G-Q).
Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Human, Mouse, Rat
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. (
Protein A or G Sepharose)
WB: 1:500~1:3000, ELISA: 1:1000
JAK2 (Phospho-Tyr570) antibody detects endogenous levels of JAK2 only when phosphorylated at tyrosine 750.
Delta-Notch Signaling Pathway
EGFR1 Signaling Pathway
Jak-STAT signaling pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of extracts from 293 cells, treated with etoposide (25uM, 24hours), using JAK2 (Phospho-Tyr570) antibody.The lane on the right is treated with the synthesized peptide.Western blot analysis of extracts from JK cells (Lane 2), using JAK2 (Phospho-Tyr570) Antibody. The lane on the left is treated with synthesized peptide.